AMGN
AMGEN INCB7215-min delayed · EOD close391.27 −0.48% downas of 2026-09-09mkt cap $212B
Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0000318154
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $38.1B | 2026-06-30 | 10-Q · 0000318154-26-000126 |
| Revenue (prior year) | $33.4B | 2024-12-31 | 10-K · 0000318154-25-000010 |
| Operating income | $11.4B | 2026-06-30 | 10-Q · 0000318154-26-000126 |
| Net income | $8.7B | 2026-06-30 | 10-Q · 0000318154-26-000126 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $95.6B | 2026-06-30 | 10-Q · 0000318154-26-000126 |
| Current assets | $35.0B | 2026-06-30 | 10-Q · 0000318154-26-000126 |
| Current liabilities | $25.5B | 2026-06-30 | 10-Q · 0000318154-26-000126 |